Two Sigma Advisers’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-222,690
| Closed | -$9.76M | – | 726 |
|
|
2025
Q4 | $9.76M | Buy |
222,690
+198,190
| +809% | +$8.2M | 0.02% | 552 |
|
|
2025
Q3 | $1.01M | Sell |
24,500
-404,290
| -94% | -$16.3M | ﹤0.01% | 1456 |
|
|
2025
Q2 | $18.9M | Sell |
428,790
-1,856,300
| -81% | -$74.2M | 0.04% | 349 |
|
|
2025
Q1 | $84.4M | Buy |
2,285,090
+657,200
| +40% | +$23.4M | 0.19% | 113 |
|
|
2024
Q4 | $54.2M | Sell |
1,627,890
-74,700
| -4% | -$2.42M | 0.13% | 159 |
|
|
2024
Q3 | $44.2M | Buy |
1,702,590
+98,000
| +6% | +$2.44M | 0.1% | 180 |
|
|
2024
Q2 | $36.1M | Sell |
1,604,590
-151,300
| -9% | -$3.36M | 0.08% | 223 |
|
|
2024
Q1 | $41.7M | Sell |
1,755,890
-84,600
| -5% | -$1.88M | 0.1% | 215 |
|
|
2023
Q4 | $44.2M | Sell |
1,840,490
-373,700
| -17% | -$8.12M | 0.1% | 197 |
|
|
2023
Q3 | $48.4M | Sell |
2,214,190
-83,800
| -4% | -$1.75M | 0.12% | 167 |
|
|
2023
Q2 | $43.9M | Buy |
2,297,990
+626,600
| +37% | +$12.1M | 0.11% | 193 |
|
|
2023
Q1 | $32.4M | Buy |
1,671,390
+560,300
| +50% | +$9.76M | 0.08% | 229 |
|
|
2022
Q4 | $17.8M | Buy |
1,111,090
+2,700
| +0.2% | +$44K | 0.05% | 373 |
|
|
2022
Q3 | $17.4M | Sell |
1,108,390
-716,500
| -39% | -$13.8M | 0.05% | 355 |
|
|
2022
Q2 | $38M | Sell |
1,824,890
-219,100
| -11% | -$4.52M | 0.11% | 200 |
|
|
2022
Q1 | $46.3M | Sell |
2,043,990
-253,600
| -11% | -$4.95M | 0.12% | 173 |
|
|
2021
Q4 | $42M | Buy |
2,297,590
+81,100
| +4% | +$1.55M | 0.11% | 175 |
|
|
2021
Q3 | $46.9M | Buy |
2,216,490
+952,900
| +75% | +$17.7M | 0.12% | 169 |
|
|
2021
Q2 | $23M | Buy |
1,263,590
+629,400
| +99% | +$14.7M | 0.06% | 300 |
|
|
2021
Q1 | $14.3M | Buy |
634,190
+153,200
| +32% | +$3.46M | 0.04% | 448 |
|
|
2020
Q4 | $9.65M | Buy |
480,990
+1,300
| +0.3% | +$27.2K | 0.03% | 581 |
|
|
2020
Q3 | $11.7M | Sell |
479,690
-507,500
| -51% | -$11.8M | 0.03% | 492 |
|
|
2020
Q2 | $23.4M | Buy |
987,190
+887,855
| +894% | +$20.6M | 0.07% | 287 |
|
|
2020
Q1 | $1.71M | Sell |
99,335
-184,300
| -65% | -$3.37M | 0.01% | 1196 |
|
|
2019
Q4 | $5M | Sell |
283,635
-391,200
| -58% | -$6.63M | 0.01% | 854 |
|
|
2019
Q3 | $11.9M | Buy |
674,835
+187,300
| +38% | +$3.79M | 0.03% | 491 |
|
|
2019
Q2 | $10.4M | Buy |
+487,535
| New | +$10.2M | 0.03% | 573 |
|
|
2019
Q1 | – | Sell |
-11,631
| Closed | -$229K | – | 2342 |
|
|
2018
Q4 | $229K | Buy |
+11,631
| New | +$207K | ﹤0.01% | 2086 |
|
|
2018
Q3 | – | Sell |
-1,081,321
| Closed | -$23.3M | – | 2281 |
|
|
2018
Q2 | $23.3M | Sell |
1,081,321
-624,400
| -37% | -$12.9M | 0.06% | 357 |
|
|
2018
Q1 | $37.8M | Sell |
1,705,721
-1,876,800
| -52% | -$51.9M | 0.1% | 253 |
|
|
2017
Q4 | $109M | Sell |
3,582,521
-566,817
| -14% | -$15.1M | 0.29% | 94 |
|
|
2017
Q3 | $101M | Sell |
4,149,338
-13,126
| -0.3% | -$349K | 0.28% | 93 |
|
|
2017
Q2 | $103M | Sell |
4,162,464
-346,757
| -8% | -$7.34M | 0.34% | 65 |
|
|
2017
Q1 | $97.7M | Buy |
4,509,221
+1,080,321
| +32% | +$22M | 0.32% | 71 |
|
|
2016
Q4 | $51.1M | Buy |
3,428,900
+1,632,797
| +91% | +$23.6M | 0.2% | 120 |
|
|
2016
Q3 | $23M | Buy |
1,796,103
+817,313
| +84% | +$8.84M | 0.1% | 231 |
|
|
2016
Q2 | $7.64M | Buy |
978,790
+270,400
| +38% | +$1.56M | 0.04% | 427 |
|
|
2016
Q1 | $2.83M | Buy |
708,390
+446,200
| +170% | +$1.89M | 0.02% | 664 |
|
|
2015
Q4 | $1.48M | Buy |
262,190
+60,694
| +30% | +$340K | 0.01% | 863 |
|
|
2015
Q3 | $1.13M | Buy |
+201,496
| New | +$1.1M | 0.01% | 961 |
|
|
2015
Q1 | – | Sell |
-24,290
| Closed | -$35K | – | 2053 |
|
|
2014
Q4 | $35K | Buy |
+24,290
| New | +$37.9K | ﹤0.01% | 2378 |
|
Other funds holding EXEL
FCM
VPM
VCM
Two Sigma Advisers's EXEL Position: Q1 2026 in Review
Two Sigma Advisers sold out of Exelixis (EXEL) in Q1 2026, closing a stake of 222,690 shares — an estimated $9.76M sold.
Two Sigma Advisers first reported a position in EXEL in Q4 2014 and held it in 41 quarters. The position peaked at $109M in Q4 2017. 694 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.
- Two Sigma Advisers reported no remaining Exelixis position as of Q1 2026 after selling out during the quarter.
- Two Sigma Advisers sold 222,690 Exelixis shares in Q1 2026, an estimated $9.76M.
- Two Sigma Advisers first reported a position in Exelixis in Q4 2014 and held it in 41 quarters.
- Two Sigma Advisers's Exelixis position peaked at $109M in Q4 2017.
- 694 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.
Based on Two Sigma Advisers's 13F filing for Q1 2026.